本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Artivion

23.64
-0.3500-1.46%
成交量:7.68萬
成交額:181.35萬
市值:10.09億
市盈率:-73.87
高:23.84
開:23.75
低:23.46
收:23.99
資料載入中...

公司資料

公司名字:
Artivion
交易所:
NYSE
成立時間:
1984
員工人數:
1600
公司地址:
1655 Roberts Boulevard NW,Kennesaw,Georgia,United States
郵編:
30144
傳真:
- -
簡介:
Artivion, Inc.於 1984 年在佛羅里達州註冊成立,並於2022年1月1日將其註冊地址從佛羅里達州更改為特拉華州,是生產,加工和分銷醫療器械和植入式人體組織的領先企業,專註於主動脈修復。 他們的醫療設備和加工組織主要包括四個產品系列:BioGlue外科膠粘劑(“BioGlue”); On-X机械心臟瓣膜和手術產品; JOTEC血管內和外科產品; 以及包括CryoValve SG肺心臟瓣膜(“CryoValve SGPV”)和CryoPatch SG肺心臟貼片(“CryoPatch SG”)在內的心臟和血管人體組織,兩者均使用其專有的SynerGraft技術加工。 其他產品包括CardioGenesis心臟激光療法,PerClot和PhotoFixTM。

董事

名稱
職位
J. Patrick Mackin
Director, President and Chief Executive Officer
Daniel J. Bevevino
Director
Harvey Morgan
Director
James W. Bullock
Director
Jeffrey H. Burbank
Director
Jon W. Salveson
Director
Marna P. Borgstrom
Director
Ronald D. McCall
Director
Thomas F. Ackerman
Director

股東

名稱
職位
J. Patrick Mackin
Director, President and Chief Executive Officer
D. Ashley Lee
Executive Vice President, Chief Operating Officer,Chief Financial Officer
Jean F. Holloway
Senior Vice President, General Counsel, Chief Compliance Officer, and Secretary
John E. Davis
Senior Vice President, Global Sales and Marketing
Michael S. Simpson
Senior Vice President, Regulatory Affairs and Quality Assurance
Amy D. Horton
Vice President and Chief Accounting Officer
Dennis B. Maier
Vice President, Operations
F. Peter Barthold
Vice President, Research and Development
Matthew A. Getz
Vice President, Human Resources
Scott B. Capps
Vice President, Clinical Research